Condition

Advanced Stage Non-small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions3

Lead sponsors shown2

Clinical trials

2 shown

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung CancerNCT05701176 · 2022-11-03

RECRUITING

Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCsNCT02350764 · 2015-01-20

COMPLETED

Common interventions

[18F]F-AraG PET scanDIAGNOSTIC_TEST1nivolumabDRUG1pilimumabDRUG1

Leading sponsors

Amsterdam UMC, location VUmc1Memorial Sloan Kettering Cancer Center1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.